229 related articles for article (PubMed ID: 28886484)
1. Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells.
Brandt KE; Falls KC; Schoenfeld JD; Rodman SN; Gu Z; Zhan F; Cullen JJ; Wagner BA; Buettner GR; Allen BG; Berg DJ; Spitz DR; Fath MA
Redox Biol; 2018 Apr; 14():82-87. PubMed ID: 28886484
[TBL] [Abstract][Full Text] [Related]
2. Labile iron affects pharmacological ascorbate-induced toxicity in osteosarcoma cell lines.
Zhou L; Zhang L; Wang S; Zhao B; Lv H; Shang P
Free Radic Res; 2020 Jun; 54(6):385-396. PubMed ID: 32183598
[TBL] [Abstract][Full Text] [Related]
3. Role of labile iron in the toxicity of pharmacological ascorbate.
Du J; Wagner BA; Buettner GR; Cullen JJ
Free Radic Biol Med; 2015 Jul; 84():289-295. PubMed ID: 25857216
[TBL] [Abstract][Full Text] [Related]
4. Impact of antioxidants on the ability of phenolic phytochemicals to kill HCT116 colon cancer cells.
Murphy A; Testa K; Berkelhammer J; Hopkins S; Loo G
Free Radic Res; 2014 Mar; 48(3):313-21. PubMed ID: 24256565
[TBL] [Abstract][Full Text] [Related]
5. D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H
Sciegienka SJ; Solst SR; Falls KC; Schoenfeld JD; Klinger AR; Ross NL; Rodman SN; Spitz DR; Fath MA
Free Radic Biol Med; 2017 Jul; 108():354-361. PubMed ID: 28389407
[TBL] [Abstract][Full Text] [Related]
6. Vitamin B12b increases the cytotoxicity of short-time exposure to ascorbic acid, inducing oxidative burst and iron-dependent DNA damage.
Solovieva ME; Soloviev VV; Akatov VS
Eur J Pharmacol; 2007 Jul; 566(1-3):206-14. PubMed ID: 17475236
[TBL] [Abstract][Full Text] [Related]
7. O
Schoenfeld JD; Sibenaller ZA; Mapuskar KA; Wagner BA; Cramer-Morales KL; Furqan M; Sandhu S; Carlisle TL; Smith MC; Abu Hejleh T; Berg DJ; Zhang J; Keech J; Parekh KR; Bhatia S; Monga V; Bodeker KL; Ahmann L; Vollstedt S; Brown H; Shanahan Kauffman EP; Schall ME; Hohl RJ; Clamon GH; Greenlee JD; Howard MA; Schultz MK; Smith BJ; Riley DP; Domann FE; Cullen JJ; Buettner GR; Buatti JM; Spitz DR; Allen BG
Cancer Cell; 2017 Apr; 31(4):487-500.e8. PubMed ID: 28366679
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide reduces oxidative stress in cancer cells by forming dinitrosyliron complexes.
Sahni S; Hickok JR; Thomas DD
Nitric Oxide; 2018 Jun; 76():37-44. PubMed ID: 29522907
[TBL] [Abstract][Full Text] [Related]
9. Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration.
Kamanna VS; Ganji SH; Shelkovnikov S; Norris K; Vaziri ND
Am J Nephrol; 2012; 35(2):114-9. PubMed ID: 22212390
[TBL] [Abstract][Full Text] [Related]
10. alpha-Tocopherol (vitamin-E) ameliorates ferric nitrilotriacetate (Fe-NTA)-dependent renal proliferative response and toxicity: diminution of oxidative stress.
Iqbal M; Rezazadeh H; Ansar S; Athar M
Hum Exp Toxicol; 1998 Mar; 17(3):163-71. PubMed ID: 9587785
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations.
Connor JR; Zhang X; Nixon AM; Webb B; Perno JR
PLoS One; 2015; 10(5):e0125272. PubMed ID: 25973894
[TBL] [Abstract][Full Text] [Related]
12. Depletion of cellular iron by bps and ascorbate: effect on toxicity of adriamycin.
Nyayapati S; Afshan G; Lornitzo F; Byrnes RW; Petering DH
Free Radic Biol Med; 1996; 20(3):319-29. PubMed ID: 8720902
[TBL] [Abstract][Full Text] [Related]
13. Labile iron potentiates ascorbate-dependent reduction and mobilization of ferritin iron.
Badu-Boateng C; Pardalaki S; Wolf C; Lajnef S; Peyrot F; Naftalin RJ
Free Radic Biol Med; 2017 Jul; 108():94-109. PubMed ID: 28336129
[TBL] [Abstract][Full Text] [Related]
14. Effect of iron and phagocytosis on murine macrophage activation in vitro.
Gauthier YP; Isoard P
Biol Trace Elem Res; 1995; 47(1-3):37-50. PubMed ID: 7779572
[TBL] [Abstract][Full Text] [Related]
15. Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A.
Glei M; Latunde-Dada GO; Klinder A; Becker TW; Hermann U; Voigt K; Pool-Zobel BL
Mutat Res; 2002 Aug; 519(1-2):151-61. PubMed ID: 12160900
[TBL] [Abstract][Full Text] [Related]
16. In vitro study on the effects of iron sucrose, ferric gluconate and iron dextran on redox-active iron and oxidative stress.
Sturm B; Steinkellner H; Ternes N; Goldenberg H; Scheiber-Mojdehkar B
Arzneimittelforschung; 2010; 60(7):459-65. PubMed ID: 20712137
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of hydroperoxide metabolism enhance ascorbate-induced cytotoxicity.
Olney KE; Du J; van 't Erve TJ; Witmer JR; Sibenaller ZA; Wagner BA; Buettner GR; Cullen JJ
Free Radic Res; 2013 Mar; 47(3):154-63. PubMed ID: 23205739
[TBL] [Abstract][Full Text] [Related]
18. Effects of pharmacological ascorbate on hemoglobin-induced cancer cell proliferation.
Lu N; Ding Y; Tian R; Yang Z; Chen J; Peng YY
Int J Biol Macromol; 2016 Nov; 92():1215-1219. PubMed ID: 27527692
[TBL] [Abstract][Full Text] [Related]
19. Tumor cells have decreased ability to metabolize H
Doskey CM; Buranasudja V; Wagner BA; Wilkes JG; Du J; Cullen JJ; Buettner GR
Redox Biol; 2016 Dec; 10():274-284. PubMed ID: 27833040
[TBL] [Abstract][Full Text] [Related]
20. Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity.
Praschberger M; Haider K; Cornelius C; Schitegg M; Sturm B; Goldenberg H; Scheiber-Mojdehkar B
Biometals; 2015 Feb; 28(1):35-50. PubMed ID: 25326244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
